Could we design the RCT as a non-inferiority trial at this situation? [Design Issues]

posted by dennis001 – Hong Kong, 2022-07-27 07:21 (630 d 10:42 ago) – Posting: # 23181
Views: 2,118

Dear ElMaestro
Thanks!

❝ Clearly a case for an NI trial one way or another.


Thank you for your comment that helped to assuage my doubts.

❝ Clearly a case for a scientific advice where you need the authority's nod for margin and design before you kick off.


Ok. we will discuss with them.

Complete thread:

UA Flag
Activity
 Admin contact
22,985 posts in 4,823 threads, 1,653 registered users;
43 visitors (0 registered, 43 guests [including 10 identified bots]).
Forum time: 18:04 CEST (Europe/Vienna)

Complex, statistically improbable things are by their nature
more difficult to explain than
simple, statistically probable things.    Richard Dawkins

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5